Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
  1. Home
  2. Publications
  3. Supplementary Table S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Supplementary Table S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Authors:
  • SASrivandana Akshintala
    Srivandana Akshintala
  • RSR. Taylor Sundby
    R. Taylor Sundby
  • DBDonna Bernstein
    Donna Bernstein
  • JGJohn W. Glod
    John W. Glod
  • RKRosandra N. Kaplan
    Rosandra N. Kaplan
  • MYMarielle E. Yohe
    Marielle E. Yohe
  • AGAndrea M. Gross
    Andrea M. Gross
  • JDJoanne Derdak
    Joanne Derdak
  • HLHaiyan Lei
    Haiyan Lei
  • APAlexander Pan
    Alexander Pan
  • EDEva Dombi
    Eva Dombi
  • IPIsabel Palacio-Yance
    Isabel Palacio-Yance

Open Access
Publisher website
Google Scholar
  • 18 July 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.23703474.v1
Abstract
Representativeness of Study Participants
Keywords
  • GROWTH FACTOR
  • STUDY PARTICIPANTS
  • SUPPLEMENTARY TABLE
  • SRC FAMILY
  • FAMILY KINASE
  • RHABDOMYOSARCOMA REPRESENTATIVENESS
  • INSULIN-LIKE GROWTH
  • TABLE
  • FACTOR
  • RECEPTOR
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.